Two Step Haplo With Radiation Conditioning
Phase 2
63
about 11 years
18+
1 site in PA
About this study
This trial is testing whether a modified conditioning regimen, using radiation and chemotherapy, can reduce treatment-related mortality (TRM) in adults undergoing hematopoietic stem cell transplant (HSCT) for certain blood cancers. This approach involves two steps: first, lower-intensity treatments are given before the transplant, followed by HSCT to cure the cancer.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Donor Lymphocyte Infusion
- 2.Receive Total-Body Irradiation
- 3.Take Cyclophosphamide
- +3 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
cyclophosphamide (Alkylating chemotherapy; crosslinks DNA strands), fludarabine, melphalan, Immunological Agents (Enzyme Inhibitors), tacrolimus
infusion, intravenous, injection
biopsy, diagnostic, radiation
Oncology